| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2802632401020 | 263240102 | NIROX F.C.TAB 300MG/TAB BTx10 (BLIST.1x10) | 3.37 | 3.53 | 4.87 |
Used to treat respiratory tract, urinary and soft tissue infections.
Roxithromycin prevents bacteria from growing, by interfering with their protein synthesis. Roxithromycin binds to the subunit 50S of the bacterial ribosome, and thus inhibits the translocation of peptides. Roxithromycin has similar antimicrobial spectrum as erythromycin, but is more effective against certain gram-negative bacteria, particularly <i>Legionella pneumophila</i>.
Most common side-effects are gastrointestinal; diarrhoea, nausea, abdominal pain and vomiting. Less common side-effects include headaches, rashes, abnormal liver function values and alteration in senses of smell and taste.
Very rapidly absorbed and diffused into most tissues and phagocytes.
12 hours